Labetalol vs hydralazine

by D Ashworth 2024involvement of women, that explores 'Treatment vs. Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

by MRF Baggio 2024 Cited by 64tance index of uterine arteries associated with hydralazine, the use of hydralazine and labetalol were not related to with p 5 0.22 (hydralazine vs.

Tivakaran vs. hydralazine. StatPearls. Malha, L, et al. (2024). Safety of Labetalol: pregnant woman taking medication . Labetalol's

A total of 573 doses of PRN IV or oral hydralazine or labetalol were administered to the 250 patients. Oral hydralazine was the most commonly administered antihypertensive agent at 90.9% of doses compared with IV hydralazine at 5.4%, oral labetalol at 3.0%, and IV labetalol at only 0.7% of doses.

Delgado De Pasquale, Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial, Pregnancy

Hydralazine Vs Labetalol in Mean Reduction of Mean Arterial Pressure in patients with Severe Preeclampsia. A Naz, Z Jawad. Pakistan journal of medical and

by A Satheeshkumar 2024IV hydralazine was preferred over PO hydralazine (23 patients vs. 6 labetalol and hydralazine. J Clin Hypertens 2024;–33

A total of 573 doses of PRN IV or oral hydralazine or labetalol were administered to the 250 patients. Oral hydralazine was the most commonly administered antihypertensive agent at 90.9% of doses compared with IV hydralazine at 5.4%, oral labetalol at 3.0%, and IV labetalol at only 0.7% of doses.

Intravenous Labetalol, Hydralazine, Sodium Nitroprusside or Nitroglycerine A comparison of no medication versus methyldopa or labetalol in chronic